HIV Diagnostics Market is estimated to be US$ 10.07 billion by 2030 with a CAGR of 10.8% during the forecast period

 

 


Human Immunodeficiency virus (HIV) causes retroviral infectious disease such as Acquired Immunodeficiency Syndrome (AIDS). HIV attacks on the body immune system specifically CD4 cells (T cells), which helps the immune system to prevent infections. HIV generally spreads through infectious blood or imparting needles, and sexual interactions. The HIV diagnosis can be done by performing viral load test, saliva test, and blood test. For most accurate results, enzyme linked immunosorbent assay (ELISA) test followed by western blot method is one of the efficient and popular method for detection of HIV. Human Immunodeficiency virus (HIV) causes Acquired Immunodeficiency Syndrome (AIDS).For the diagnosis of HIV blood test, saliva test, urine test and viral load test are carried out. HIV is most commonly diagnosed by doing a urine test and blood test. But, enzyme linked immunosorbent assay (ELISA) test followed by Western Bloat Method is one of the most efficient methods for obtaining the results. The Global HIV Diagnostics Market accounted for US$ 3.6 billion in 2020 and is estimated to be US$ 10.07 billion by 2030 and is anticipated to register a CAGR of 10.8%.

 

The report “ HIV Diagnostics Market, By Product (Consumables, Instrument, and Software & Services), By Test Type (Antibody Tests (HIV-1 Screening Tests, HIV-1 Confirmatory Tests and HIV-2 & Group O Diagnostic Tests), Viral Load Tests, CD4 Count Tests, Tests for Early Infant Diagnosis, and Tests for Viral Identification), By End User (Diagnostic Laboratories, Hospitals, Blood Banks, Home Care Settings and Others), and Region - Global Forecast to 2029" Global HIV Diagnostics Market accounted for US$ 3.6 billion in 2020 and is estimated to be US$ 10.07 billion by 2030 and is anticipated to register a CAGR of 10.8%. Global HIV diagnostics market is driven by increasing incidences of HIV/AIDS across the globe and various governmental initiatives by countries to generate the awareness of HIV in people.

Key Highlights:

·         In 2018, Abbott Healthcare and Chennai’s YR Gaitonde Centre for AIDS Research and Education entered into a partnership to study the country’s viral diversity to improve the accuracy of diagnostic tests for HIV.

·         In 2017, researchers at University of Illinois, Urbana Campaign, developed a portable spectral analyzer based on ELISA assay that enables a smartphone to perform lab grade medical diagnostic tests, which usually requires expensive instruments.

Key Market Insights from the report:          

Global HIV Diagnostics Market accounted for US$ 3.6 billion in 2020 and is estimated to be US$ 10.07 billion by 2030 and is anticipated to register a CAGR of 10.8% . The market report has been segmented on the basis of product, test type, end user and region.

·         By product, global HIV diagnosis market is segmented into consumables, instrument, and software and services.

·         By test type, global HIV diagnosis market is segmented into antibody tests, viral load tests, CD4 count tests, test for early infant diagnosis, and tests for viral identification.

·         By end user, global HIV diagnosis market is segmented into diagnostic laboratories, hospitals, Blood Banks, Home Care Settings and Others.

·         By region, North America region accounted major share in global HIV diagnostics market. This is owing to factors such as Supportive government initiatives and funding for increasing HIV diagnosis procedures and creating awareness among the population.

Before purchasing this report, request a sample or make an inquiry by clicking the following link:

https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/2230

The prominent player operating in the global HIV diagnostics market include Cepheid, BD Biosciences, Roche Diagnostics, Zyomyx Incorporation, Merck & Co., Inc., Bristol –Myres Squibb, Johnson & Johnson, Hologic Incorporation, Chembio Diagnostic Systems, and Abbott Laboratories.

About Prophecy Market Insights

Prophecy Market Insights is a specialized market research, analytics, marketing and business strategy, and solutions company that offer strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high value opportunities in the target business area. Also, we help our client to address business challenges and provide best possible solutions to overcome them and transform their business.

Contact Us:

Sales

Prophecy Market Insights

Email- sales@prophecymarketinsights.com

 

Comments

Post a Comment

Popular posts from this blog

Patient Portal Market is estimated to be US$ 7862.01 billion by 2030 with a CAGR of 11.50% during the forecast period

Image
  Patient Portal Market  accounted for US$ 2643.21 million in 2020 and is estimated to be US$ 7862.01 million by 2030 and is anticipated to register a CAGR of 11.50%. The patients can share and view their health information and communicate remotely. These characteristics enables patients to look into various data points, such as diagnostic test results, medical history, and prescription information. Patient portal is one of the many tools that allow the healthcare payers and providers to arrive at outcomes, which are patient-centric. Rapid technological advancements in the digital space are rising the engagement level of patients in the entire healthcare ecosystem. Data points collected on a per-patient basis through patient portal can be used for performing pin-point diagnosis, designing better clinical trials, and helping in the elimination of administration of redundant therapies and drugs to individual patients. The report   "   Global Patient Portal Market, By P...
Read more

Knee Replacement Market is estimated to be 14.2 billion by 2029 with a CAGR of 4.3% during the forecasted period.

Image
  knee replacement market  accounted for 9.7 billion in 2020 and is estimated to be US$ 14.2 billion by 2029 and is anticipated to register a CAGR of 4.3%. The report " Global Knee Replacement Market, By Product ( Total Knee Replacement, Partial Knee Replacement, Kneecap Replacement, and Complex (or revision) Knee Replacement),  By End Users ( Hospitals, Orthopedic Centers, and Other ),  and By Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa) - Trends, Analysis and Forecast till 2029” . Key Highlights: In March 2018, Smith and Nephew announced commercial release of bi-cruciate retaining Journey II XR total knee arthroplasty across the U.S. and Japan. The product launch was aimed at capturing large customer base with innovative product offering. In October 2018, Zimmer Biomet Holdings announced to collaborate with Apple to facilitate patient and surgeon connection during the knee and hip replacement procedures. Th...
Read more

Nuclear Medicine Market is estimated to be US$ 6.49 billion by 2030 with a CAGR of 4.30% during the forecast period

Image
  The Nuclear Medicine Market accounted for US$ 4.26 billion and is estimated to be US$ 6.49 billion by 2030 with a CAGR of 4.30% during the forecast period. Nuclear medicine may be a medicine involving the appliance of radioactive substances within the diagnosis and treatment of disease. Medicine imaging, during a sense, is "radiology done inside out" or "endoradiology" because it records radiation emitting from within the body instead of radiation that's generated by external sources like X-rays. Additionally, medicine scans differ from radiology, because the emphasis isn't on imaging anatomy, but on the function. For such reason, it's called a physiological imaging modality. Single photon emission computerized tomography (SPECT) and positron emission tomography (PET) scans are the 2 commonest imaging modalities in medicine.   The report "  Global Nuclear Medicine Market, By Diagnostics (Single Photon Emission, Computed Tomography (SPECT), an...
Read more